Is CUMBERLAND PHARMACEUTICALS INC (CPIX) Halal?

NASDAQ Healthcare United States $46M
✗ NOT HALAL
Confidence: 90/100
CUMBERLAND PHARMACEUTICALS INC (CPIX) is Not Halal under AAOIFI Standard 21. The company's debt ratio of 39.3% exceeds the 30% threshold, indicating excessive interest-bearing debt relative to market capitalization. CUMBERLAND PHARMACEUTICALS INC operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 39.3%
/ 30%
34.3%
/ 30%
22.3%
/ 30%
0.88%
/ 5%
✗ NOT HALAL
DJIM 39.3%
/ 33%
34.3%
/ 33%
22.3%
/ 33%
0.88%
/ 5%
✗ NOT HALAL
MSCI 27.2%
/ 33%
23.8%
/ 33%
15.5%
/ 33%
0.88%
/ 5%
✓ HALAL
S&P 39.3%
/ 33%
34.3%
/ 33%
22.3%
/ 33%
0.88%
/ 5%
✗ NOT HALAL
FTSE 27.2%
/ 33%
23.8%
/ 33%
15.5%
/ 50%
0.88%
/ 5%
✓ HALAL

Financial Highlights

EPS
$-0.19
P/B Ratio
1.8
EV/EBITDA
32.7
EV: $44M
Revenue
$45M
Growth: 31.1%
Beta
-0.5
Low volatility
Current Ratio
1.0

Profitability

Gross Margin 85.0%
Operating Margin -10.0%
Net Margin -6.4%
Return on Equity (ROE) -12.2%
Return on Assets (ROA) -2.3%

Cash Flow & Balance Sheet

Operating Cash Flow$5M
Free Cash Flow$5M
Total Debt$10M
Debt-to-Equity41.5
Current Ratio1.0
Total Assets$77M

Price & Trading

Last Close$3.24
50-Day MA$3.73
200-Day MA$3.43
Avg Volume179K
Beta-0.5
52-Week Range
$1.85
$6.27

About CUMBERLAND PHARMACEUTICALS INC (CPIX)

CEO
Mr. A. J. Kazimi MBA
Employees
93
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
United States
Exchange
NASDAQ
Market Cap
$46M
Currency
USD

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment; Vaprisol, an injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections; and Tacilia, an oral capsule for the treatment of H. pylori infection. It also develops ifetroban, a product candidate that has completed Phase II clinical trials for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy, hepatorenal syndrome, portal hypertension, aspirin-exacerbated respiratory disease, systemic sclerosis, and idiopathic pulmonary fibrosis. It serves hospital acute care, gastroenterology, and oncology markets in the United States, China, South Korea, Russia, Mexico, Australia, and Saudi Arabia. The company has a strategic alliance agreement with WinHealth Pharma Group Co. Limited. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is CUMBERLAND PHARMACEUTICALS INC (CPIX) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), CUMBERLAND PHARMACEUTICALS INC is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is CUMBERLAND PHARMACEUTICALS INC's debt ratio?

CUMBERLAND PHARMACEUTICALS INC's debt ratio is 39.3% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 27.2%.

What are CUMBERLAND PHARMACEUTICALS INC's key financial metrics?

CUMBERLAND PHARMACEUTICALS INC has a market capitalization of $46M, and revenue of $45M. The company maintains a gross margin of 85.0% and a net margin of -6.4%. Return on equity stands at -12.2%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.